INO:US
$1.885
4.722%
Inovio Pharmaceuticals Inc.News & Events
Last updated: May 12, 2025, 11:58 AM ET
INOVIO to Present at Upcoming Scientific and Investor Conferences
PR Newswire APR 30, 2025 8:05 AM EDTINOVIO to Present at Upcoming Scientific and Investor Conferences PR Newswire ...READ ARTICLEINOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
PR Newswire APR 29, 2025 8:05 AM EDTINOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 PR Newswire ...READ ARTICLEINOVIO to Present at Upcoming Scientific Conferences
PR Newswire APR 9, 2025 8:05 AM EDTINOVIO to Present at Upcoming Scientific Conferences PR Newswire PLYMOUTH M...READ ARTICLEINOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
PR Newswire MAR 18, 2025 4:05 PM EDTINOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights ...READ ARTICLEINOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
PR Newswire MAR 13, 2025 6:15 PM EDTINOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-En...READ ARTICLEINOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
PR Newswire MAR 12, 2025 12:55 PM EDTINOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025 P...READ ARTICLEClinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
PR Newswire FEB 12, 2025 8:00 AM ESTClinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent ...READ ARTICLEImmune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
PR Newswire FEB 10, 2025 8:05 AM ESTImmune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer ...READ ARTICLEINOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
PR Newswire JAN 29, 2025 4:14 PM ESTINOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference ...READ ARTICLEINOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
PR Newswire JAN 9, 2025 8:04 AM ESTINOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments PR Newswire ...READ ARTICLE